Wuhan Net Debt from 2010 to 2024

300871 Stock   12.62  0.08  0.64%   
Wuhan Hvsen's Net Debt is increasing over the years with slightly volatile fluctuation. Net Debt is expected to dwindle to about 503.1 M. Net Debt is the total debt of Wuhan Hvsen Biotechnology minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals
 
Net Debt  
First Reported
2010-12-31
Previous Quarter
548.4 M
Current Value
503.1 M
Quarterly Volatility
56.7 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Wuhan Hvsen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Wuhan Hvsen's main balance sheet or income statement drivers, such as Interest Expense of 29.6 M, Other Operating Expenses of 5.6 M or Net Income Applicable To Common Shares of 96.4 M, as well as many indicators such as . Wuhan financial statements analysis is a perfect complement when working with Wuhan Hvsen Valuation or Volatility modules.
  
This module can also supplement various Wuhan Hvsen Technical models . Check out the analysis of Wuhan Hvsen Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Wuhan Stock

Wuhan Hvsen financial ratios help investors to determine whether Wuhan Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Wuhan with respect to the benefits of owning Wuhan Hvsen security.